Jesús
San Miguel Izquierdo
Consultor Investigador
University of Leipzig
Leipzig, AlemaniaPublikationen in Zusammenarbeit mit Forschern von University of Leipzig (2)
2023
2022
-
Corrigendum to “OAB-005: Update of safety and efficacy of Isatuximab short-duration fixed-volume infusion plus Bortezomib, Lenalidomide, and Dexamethasone combined therapy for NDMM ineligible/with no immediate intent for ASCT” [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S3-S4](S2152265021X00122)
Clinical Lymphoma, Myeloma and Leukemia